Correlation of Particulate Matter and Heme Oxygenase-1 Protein Activity in Asthmatic Children by Induced Sputum Analysis.

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2009 by Tel-Aviv Sourasky Medical Center.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Tel-Aviv Sourasky Medical Center
ClinicalTrials.gov Identifier:
NCT00969670
First received: August 29, 2009
Last updated: November 21, 2009
Last verified: November 2009
  Purpose

Samples of sputum from asthmatic children, between 5-17 years, will be collected during two years of the study period to perform tests Particle Size Distribution (PSD) and Shape Analysis (SA) of the particulate matter in the sputum and a biochemical reaction to evaluate the activity of Heme Oxygenase-1 protein in sputum cell supernatants.

Each child will perform Pulmonary Function Testing (PFT) and Induced Sputum (IS) as a routine part of diagnosis of asthma.

Parents will be asked to complete a questionnaire including questions on their child's respiratory symptoms in the last 12 months as well as socioeconomic factors. Parents will be asked to give informed written consent for their child's participation in the study.


Condition
Asthma

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
Official Title: Correlation of Particulate Matter and Heme Oxygenase-1 Protein Activity in Asthmatic Children by Induced Sputum Analysis.

Resource links provided by NLM:


Further study details as provided by Tel-Aviv Sourasky Medical Center:

Biospecimen Retention:   Samples Without DNA

Samples of indused sputum


Estimated Enrollment: 100
Study Start Date: October 2009
  Eligibility

Ages Eligible for Study:   5 Years to 17 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Children, between 5-17 years, performing a routine diagnosis of asthma in Tel Aviv Sourasky Medical Center

Criteria

Inclusion Criteria:

  • •All children, between 5-17 years, performing a routine diagnosis of asthma in Tel Aviv Sourasky Medical Center that there parents gave informed written consent for their child's participation in the study.

Exclusion Criteria:

  • None.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00969670

Locations
Israel
Pulmonary Laboratory of Tel Aviv Sourasky Medical Center Recruiting
Tel Aviv, Israel
Contact: Elizabeth Fierman, PhD       lizif@tasmc.health.gov.il   
Contact: Daria Bliznuk, BcS       dasha_bl@yahoo.com   
Principal Investigator: Elizabeth Fierman, PhD         
Sponsors and Collaborators
Tel-Aviv Sourasky Medical Center
  More Information

No publications provided

Responsible Party: Elizabeth Fierman, PhD, Tel-Aviv Sourasky Medical Center
ClinicalTrials.gov Identifier: NCT00969670     History of Changes
Other Study ID Numbers: TASMC-09-LF-242-CTIL
Study First Received: August 29, 2009
Last Updated: November 21, 2009
Health Authority: Israel: Ethics Commission

Additional relevant MeSH terms:
Asthma
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases

ClinicalTrials.gov processed this record on July 22, 2014